Biosergen applies to delist shares from Nasdaq First North Growth Market
Biosergen AB said it has applied to delist its shares from the Nasdaq First North Growth Market, conditional upon completion of its merger with Flerie.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.